Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Mullana-Ambala 133207, Haryana, India.
Molecules. 2022 Aug 4;27(15):4970. doi: 10.3390/molecules27154970.
The longstanding progressive neurodegenerative conditions of the central nervous system arise mainly due to deterioration, degradation and eventual neuronal cell loss. As an individual ages, the irreversible neurodegenerative disorders associated with aging also begin to develop, and these have become exceedingly prominent and pose a significant burden mentally, socially and economically on both the individual and their family. These disorders express several symptoms, such as tremors, dystonia, loss of cognitive functions, impairment of motor activity leading to immobility, loss of memory and many more which worsen with time. The treatment employed in management of these debilitating neurodegenerative disorders, such as Parkinson's disease (which mainly involves the loss of dopaminergic neurons in the nigrostriatal region), Alzheimer's disease (which arises due to accumulation of Tau proteins causing diffusive atrophy in the brain), Huntington's disease (which involves damage of striatal and spinal neurons, etc.), have several adverse effects, leading to exploration of several lead targets and molecules existing in herbal drugs. The current review highlights the mechanistic role of natural products in the treatment of several neurodegenerative and cerebrovascular diseases such as Parkinson's disease, Alzheimer's disease, ischemic stroke and depression.
中枢神经系统的长期进行性神经退行性疾病主要是由于退化、降解和最终的神经元细胞丢失引起的。随着个体年龄的增长,与衰老相关的不可逆转的神经退行性疾病也开始出现,这些疾病在个体及其家庭的精神、社会和经济方面都带来了极大的负担,表现出多种症状,如震颤、肌张力障碍、认知功能丧失、运动活动障碍导致的活动能力丧失、记忆力丧失等,而且这些症状会随着时间的推移而恶化。在这些使人衰弱的神经退行性疾病的治疗中,如帕金森病(主要涉及黑质纹状体区域的多巴胺能神经元丧失)、阿尔茨海默病(由于 Tau 蛋白的积累导致大脑弥散性萎缩引起的)、亨廷顿病(涉及纹状体和脊髓神经元的损伤等),所采用的治疗方法有许多副作用,这导致了对草药中存在的几种潜在靶点和分子的探索。本综述重点介绍了天然产物在治疗几种神经退行性和脑血管疾病(如帕金森病、阿尔茨海默病、缺血性中风和抑郁症)中的作用机制。